Eli Lilly LLY
NYSE LLY
$1,445.71 +8.42 (+0.59%)
As of: Nov 12, 2026 · 1:00 PM EST

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Eli Lilly's Return on Invested Capital [ROIC] came in at 38.16% for Q3 2026, up 4.48 percentage points from 33.68% a year earlier and up 0.99 percentage points from the prior quarter.

Analysis

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Return on Invested Capital [ROIC] was 40.07%, up 7.90 percentage points from FY2024.

  • Return on Invested Capital [ROIC] carries a five-year change of +11.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Invested Capital [ROIC] was 32.17% in FY2024 (+6.18 pp), 25.99% in FY2023 (-1.80 pp), 27.79% in FY2022 (+0.37 pp) and 27.42% in FY2021 (-1.51 pp).
  • The Q3 2026 figure represents the highest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2010.
  • Year-over-year, Return on Invested Capital [ROIC] has increased for 11 consecutive quarters, with an average year-over-year change of +5.91 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q1 2026 (a gain of 7.76 percentage points), and the weakest in Q2 2023 (a drop of 8.00 percentage points).
  • Business Quant data shows LLY's Return on Invested Capital [ROIC] at 37.16% (Q2 2026), 37.83% (Q1 2026) and 34.61% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 30.89%
Jun 30, 2026 32.88%
Mar 31, 2026 35.69%
Dec 31, 2025 31.29%
Sep 30, 2025 30.73%
Jun 30, 2025 25.83%
Mar 31, 2025 23.07%
Dec 31, 2024 24.08%
Sep 30, 2024 38,853,998.38%
Jun 30, 2024 23,318,923.90%
Mar 31, 2024 11,725,477.64%
Dec 31, 2023 12,851,637.57%
Sep 30, 2023 3,264,732.58%
Jun 30, 2023 14,630,812.65%
Mar 31, 2023 35,305,082.65%
Dec 31, 2022 38,566,192.65%
Sep 30, 2022 -19,220,831.20%
Jun 30, 2022 22.13%
Mar 31, 2022 -18,015,572.80%
Dec 31, 2021 -18,271,602.39%
API Access

Eli Lilly Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY